635 related articles for article (PubMed ID: 17125481)
1. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer.
Blaivas JG; Weiss JP; Jones M
BJU Int; 2006 Dec; 98(6):1233-7; discussion 1237. PubMed ID: 17125481
[TBL] [Abstract][Full Text] [Related]
2. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
Lehrer S; Cesaretti J; Stone NN; Stock RG
BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
[TBL] [Abstract][Full Text] [Related]
3. Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms.
Kuo HC
Urology; 2007 Aug; 70(2):272-6. PubMed ID: 17826488
[TBL] [Abstract][Full Text] [Related]
4. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
[TBL] [Abstract][Full Text] [Related]
5. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
6. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
Ghalayini IF; Al-Ghazo MA; Pickard RS
BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
[TBL] [Abstract][Full Text] [Related]
8. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
Roehrborn CG; Kaplan SA; Jones JS; Wang JT; Bavendam T; Guan Z
Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting for urinary incontinence after prostate brachytherapy.
McElveen TL; Waterman FM; Kim H; Dicker AP
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1395-404. PubMed ID: 15275725
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy for prostate cancer: is the pretreatment prostate volume important?
Meyer JP; Bell CR; Elwell C; Kunkler RB
BJU Int; 2008 Dec; 102(11):1585-8. PubMed ID: 18990138
[TBL] [Abstract][Full Text] [Related]
11. Comparison of voiding parameters in men and women with lower urinary tract symptoms.
Ku JH; Oh SJ
Neurourol Urodyn; 2006; 25(1):13-8. PubMed ID: 16049917
[TBL] [Abstract][Full Text] [Related]
12. Urodynamic evaluation of patients with lower urinary tract symptoms and small prostate volume.
Gomes CM; Nunes RV; Araújo RM; Sacomani CR; Trigo-Rocha FE; Bruschini H; Srougi M
Urol Int; 2008; 81(2):129-34. PubMed ID: 18758208
[TBL] [Abstract][Full Text] [Related]
13. Data from frequency-volume charts versus maximum free flow rate, residual volume, and voiding cystometric estimated urethral obstruction grade and detrusor contractility grade in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Van Venrooij GE; Eckhardt MD; Boon TA
Neurourol Urodyn; 2002; 21(5):450-6. PubMed ID: 12232879
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
[TBL] [Abstract][Full Text] [Related]
15. Modified transurethral resection of the prostate (TURP) for men with moderate lower urinary tract symptoms (LUTS) before brachytherapy is safe and feasible.
Brousil P; Hussain M; Lynch M; Laing RW; Langley SE
BJU Int; 2015 Apr; 115(4):580-6. PubMed ID: 24802744
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms.
Liao CH; Chung SD; Kuo HC
Int J Clin Pract; 2011 May; 65(5):552-8. PubMed ID: 21489080
[TBL] [Abstract][Full Text] [Related]
17. An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin.
Gerber GS; Kim JH; Contreras BA; Steinberg GD; Rukstalis DB
Urology; 1996 Jun; 47(6):840-4. PubMed ID: 8677574
[TBL] [Abstract][Full Text] [Related]
18. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM
Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239
[TBL] [Abstract][Full Text] [Related]
19. Clinical diagnosis of bladder outlet obstruction in men with lower urinary tract symptoms: reliability of commonly measured parameters and the role of idiopathic detrusor overactivity.
Vesely S; Knutson T; Fall M; Damber JE; Dahlstrand C
Neurourol Urodyn; 2003; 22(4):301-5. PubMed ID: 12808704
[TBL] [Abstract][Full Text] [Related]
20. The effects of isolated posterior compartment defects on lower urinary tract symptoms and urodynamic findings.
Cole EE; Kaufman MR; Scarpero HM; Dmochowski RR
BJU Int; 2006 May; 97(5):1024-6. PubMed ID: 16643484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
